Literature DB >> 12072772

The importance of renal localization with MIBG scintigraphy.

Yang-Yi Ong1, Deborah Cohn, Johan Wijaya, Paul Roach.   

Abstract

Although I-123 metaiodobenzylguanidine (MIBG) imaging is a well-validated technique for identification and evaluation of a pheochromocytoma, accurate interpretation can be confounded by tracer retention within the renal pelvis. The authors report two cases of abnormal MIBG accumulation in which renal localization was essential. In the first case, renal localization revealed uptake inferomedial to the left kidney in what was proved to be an extra-adrenal paraganglioma. In the second case, MIBG uptake in a similar location on the right was caused by uptake in the renal pelvis, a physiologic finding. When the location of MIBG uptake in the upper abdomen is uncertain, a renal scan should be obtained to exclude the possibility of radiolabeled MIBG tracer retention within the collecting system, a potential false-positive diagnosis of pheochromocytoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072772     DOI: 10.1097/00003072-200207000-00002

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  3 in total

1.  123I-Metaiodobenzylguanidine accumulation in a urinoma and cortex of an obstructed kidney after surgical resection of an abdominal neuroblastoma.

Authors:  Efstratios Moralidis; Georgios Arsos; Eugenia Papakonstantinou; Maria Badouraki; Dimitrios Koliouskas; Constantinos Karakatsanis
Journal:  Pediatr Radiol       Date:  2007-10-02

2.  Routine preoperative (123)I-MIBG scintigraphy for patients with phaeochromocytoma is not necessary.

Authors:  Radu Mihai; Fergus Gleeson; Derek Roskell; Andrew Parker; Greg Sadler
Journal:  Langenbecks Arch Surg       Date:  2008-07-29       Impact factor: 3.445

3.  [123I-Metaiodobenzylguanidine- (MIBG-) scintigraphy: paradoxical positivity in an oncocytic adrenocortical carcinoma].

Authors:  B-C Padberg; T Rordorf; S L Suter; D Pfeiffer; D Wild; S Schröder
Journal:  Pathologe       Date:  2007-07       Impact factor: 0.973

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.